In contrast, BARX2 expression was downregulated in breast invasive carcinoma (BRCA), colon adenocarcinoma (COAD), head and neck squamous cell carcinoma (HNSC), rectum adenocarcinoma (READ), and thyroid carcinoma (THCA). Here, BARX2 is linked to rectum adenocarcinoma.